BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 22422832)

  • 1. Credibility of claims of subgroup effects in randomised controlled trials: systematic review.
    Sun X; Briel M; Busse JW; You JJ; Akl EA; Mejza F; Bala MM; Bassler D; Mertz D; Diaz-Granados N; Vandvik PO; Malaga G; Srinathan SK; Dahm P; Johnston BC; Alonso-Coello P; Hassouneh B; Walter SD; Heels-Ansdell D; Bhatnagar N; Altman DG; Guyatt GH
    BMJ; 2012 Mar; 344():e1553. PubMed ID: 22422832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review reveals that the credibility of subgroup claims in low back pain trials was low.
    Saragiotto BT; Maher CG; Moseley AM; Yamato TP; Koes BW; Sun X; Hancock MJ
    J Clin Epidemiol; 2016 Nov; 79():3-9. PubMed ID: 27297201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subgroup analysis in haematologic malignancies phase III clinical trials: A systematic review.
    Báez-Gutiérrez N; Rodríguez-Ramallo H; Flores-Moreno S; Abdel-Kader Martín L
    Br J Clin Pharmacol; 2021 Jul; 87(7):2635-2644. PubMed ID: 33270263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review.
    Sun X; Briel M; Busse JW; You JJ; Akl EA; Mejza F; Bala MM; Bassler D; Mertz D; Diaz-Granados N; Vandvik PO; Malaga G; Srinathan SK; Dahm P; Johnston BC; Alonso-Coello P; Hassouneh B; Truong J; Dattani ND; Walter SD; Heels-Ansdell D; Bhatnagar N; Altman DG; Guyatt GH
    BMJ; 2011 Mar; 342():d1569. PubMed ID: 21444636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Evidence of Statistical Support and Corroboration of Subgroup Claims in Randomized Clinical Trials.
    Wallach JD; Sullivan PG; Trepanowski JF; Sainani KL; Steyerberg EW; Ioannidis JP
    JAMA Intern Med; 2017 Apr; 177(4):554-560. PubMed ID: 28192563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials.
    Sun X; Briel M; Busse JW; Akl EA; You JJ; Mejza F; Bala M; Diaz-Granados N; Bassler D; Mertz D; Srinathan SK; Vandvik PO; Malaga G; Alshurafa M; Dahm P; Alonso-Coello P; Heels-Ansdell DM; Bhatnagar N; Johnston BC; Wang L; Walter SD; Altman DG; Guyatt GH
    Trials; 2009 Nov; 10():101. PubMed ID: 19900273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals.
    Gabler NB; Duan N; Raneses E; Suttner L; Ciarametaro M; Cooney E; Dubois RW; Halpern SD; Kravitz RL
    Trials; 2016 Jul; 17(1):320. PubMed ID: 27423688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncology.
    Barton S; Peckitt C; Sclafani F; Cunningham D; Chau I
    Eur J Cancer; 2015 Dec; 51(18):2732-9. PubMed ID: 26608121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting and interpretation of subgroup analyses in heart failure randomized controlled trials.
    Khan MS; Khan MAA; Irfan S; Siddiqi TJ; Greene SJ; Anker SD; Sreenivasan J; Friede T; Tahhan AS; Vaduganathan M; Fonarow GC; Butler J
    ESC Heart Fail; 2021 Feb; 8(1):26-36. PubMed ID: 33254286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
    Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
    Int J Evid Based Healthc; 2005 Jul; 3(6):147-67. PubMed ID: 21631747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study.
    Liu P; Ioannidis JPA; Ross JS; Dhruva SS; Luxkaranayagam AT; Vasiliou V; Wallach JD
    BMC Med; 2019 Oct; 17(1):188. PubMed ID: 31639007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trials published in higher vs. lower impact journals differ in design, conduct, and analysis.
    Bala MM; Akl EA; Sun X; Bassler D; Mertz D; Mejza F; Vandvik PO; Malaga G; Johnston BC; Dahm P; Alonso-Coello P; Diaz-Granados N; Srinathan SK; Hassouneh B; Briel M; Busse JW; You JJ; Walter SD; Altman DG; Guyatt GH
    J Clin Epidemiol; 2013 Mar; 66(3):286-95. PubMed ID: 23347852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications.
    Kasenda B; Schandelmaier S; Sun X; von Elm E; You J; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Meerpohl JJ; Stegert M; Olu KK; Tikkinen KA; Neumann I; Carrasco-Labra A; Faulhaber M; Mulla SM; Mertz D; Akl EA; Bassler D; Busse JW; Ferreira-González I; Lamontagne F; Nordmann A; Gloy V; Raatz H; Moja L; Rosenthal R; Ebrahim S; Vandvik PO; Johnston BC; Walter MA; Burnand B; Schwenkglenks M; Hemkens LG; Bucher HC; Guyatt GH; Briel M;
    BMJ; 2014 Jul; 349():g4539. PubMed ID: 25030633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance with trial registration in five core journals of clinical geriatrics: a survey of original publications on randomised controlled trials from 2008 to 2012.
    Mann E; Nguyen N; Fleischer S; Meyer G
    Age Ageing; 2014 Nov; 43(6):872-6. PubMed ID: 24982096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Justification and reporting of subgroup analyses were lacking or inadequate in randomized controlled trials.
    Fan J; Song F; Bachmann MO
    J Clin Epidemiol; 2019 Apr; 108():17-25. PubMed ID: 30557676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic survey identified 36 criteria for assessing effect modification claims in randomized trials or meta-analyses.
    Schandelmaier S; Chang Y; Devasenapathy N; Devji T; Kwong JSW; Colunga Lozano LE; Lee Y; Agarwal A; Bhatnagar N; Ewald H; Zhang Y; Sun X; Thabane L; Walsh M; Briel M; Guyatt GH
    J Clin Epidemiol; 2019 Sep; 113():159-167. PubMed ID: 31132471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quality of reports of randomized trials in multiple sclerosis: a review.
    Signori A; Baccino A; Sormani MP
    Mult Scler; 2012 Jun; 18(6):776-81. PubMed ID: 22495947
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.